European Healthcare Expenditure on Medical Goods (Non Specified by Function) by NPISH Financing Schemes Share by Country (Million Euros)

In 2023, European healthcare expenditure on medical goods (not specified by function) showed varied trends across countries, driven by NPISH financing schemes. The United Kingdom led with 93.67 million euros, experiencing a growth of 4.66%. Estonia saw the highest increase at 9.41%, while Latvia and Switzerland faced declines of 21.82% and 32.2%, respectively. Notably, Iceland, Poland, Slovenia, and Croatia also experienced moderate growths of 4.86%, 5.59%, 6.47%, and 5.92%. Portugal and Switzerland registered the lowest expenditures among the listed countries, with nominal values near zero.

Looking ahead, future trends involve a potential increase in healthcare digitization, which could reshape NPISH financing. Plan for an increased focus on cost efficiency, equitable access, and medical innovations in these schemes to guide future expenditure patterns across Europe.